ArticleVeterinary sciences2025
Optimizing Low Crude Protein Diets with Coated Cysteamine Hydrochloride and Exogenous Alkaline Protease Supplementation in Broiler Chickens.
Article in Veterinary sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Decreasing crude protein (CP) in broiler diets can improve sustainability but may compromise growth performance. Feed additives like coated cysteamine hydrochloride (CSH) and exogenous alkaline protease (EAP) can enhance protein utilization and promote gut health. While CSH modulates metabolism, EAP improves digestibility, but their combined effects in low CP diets remain unclear. This study examines the synergistic impact of CSH and EAP on broiler growth, gut histology, carcass traits, immune response, and nutrient digestibility, aiming to optimize performance while reducing environmental impact. Six-hundred, 1-day-old broiler Ross-308 chicks (male) were allotted to four treatments, each consisting of six replicates of twenty-five birds, in a factorial arrangement using a completely randomized design. The treatments comprised two inclusion levels of coated CSH (0.2 and 0.4 g/kg with or without EAP (0 and 0.2 g/kg) in reduced CP diets. A ten percent reduction in CP from the standard requirements of Ross-308 (20.7% vs. 23% in the starter, 19.35% vs. 21.5% in the grower, and 17.55% vs. 19.5% in the finisher phase) was made in all the dietary treatments. A notable interaction (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.